Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 03/19/24 08:01:00 on US and Canada Markets.
BERKELEY, Calif. and MAINZ, Germany, March 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, will be organizing the HALLO DOC! event, infor...
REDWOOD CITY, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) in mast cell driven diseases such as chronic spontaneous urticaria (CSU) and ...
Reiterates Full year 2024 Outlook Company Hosting Investor Day Today Beginning at Noon ET PARSIPPANY, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC), which is hosting its first Investor Day today at its new East Point campus in Geo...
2024-03-19 08:00:07 ET FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – March 19, 2024 – The U.S. Federal Drug Administration (FDA) has now designated psilocybin, a classical compound found in “magic mushrooms,” as a ...
2024-03-19 08:00:07 ET FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – March 19, 2024 – The U.S. Federal Drug Administration (FDA) has now designated psilocybin, a classical compound found in “magic mushrooms,” as a ...
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference c...
BRIDGEWATER, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inf...
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian cancer (HBOC) syndrome showing that when tumors exhibited higher overall numbers of structural varia...
Ribbon and Cisco Demonstrate 1.2 Tbps Interoperability at OFC 2024 Canada NewsWire First reported display of interoperable multivendor ecosystem for highest commercial transmission speeds available PLANO, Texas , March 19, 2024 /CNW/ -- Ribbon Commu...
While mortgage rates remain elevated, they’re not as volatile as they were at the height of the pandemic, which has helped stabilize home price growth (NASDAQ: RDFN) — Home price growth is finally back to where it was before the pandemic, according to a new report from...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
37.12%Change Percent:
Alpha Teknova Inc. Company Name:
TKNO Stock Symbol:
NASDAQ Market:
teknova.com Website: